Grace Halsey

500 S TRIMBLE RD

Articles

Two Plasma Proteins May Serve as Early Biomarkers for Alzheimer Dementia and Help Explain Sex Differences, Study Suggests

January 23, 2025

Levels of acetyl-L-carnitine and free carnitine correlated significantly with disease severity, particularly in women with moderate and severe Alzheimer dementia.

Most People Who Monitor Health with Wearable Devices Don't Share Data with Clinicians

January 22, 2025

Only 25% of people who self-monitor health use the data to inform their physicians.

Landmark International Trial Seeks to Intercept and Prevent Crohn Disease Using Biomarkers

January 22, 2025

The INTERCEPT project aims to build a blood risk score that can identify individuals with a high risk of developing Crohn disease within 5 years of initial evaluation.

Attitudes Toward Vaccines in the Chronic Conditions Community: Survey Highlights

January 22, 2025

Hesitancy about vaccination against dangerous communicable diseases remains a public health problem, particularly when the hesitant are living with immunocompromising conditions.

GLP-1 Mimetic Benefits Are Broad, New Study Finds, But Risks Can't Be Ignored

January 21, 2025

Incretin-mimetics may have even broader application against disease than scientists can predict, but the risks are real, too, according to a study of 2 million.

Ascletis Enters Small Molecule Oral GLP-1 RA Category with Positive Phase 1a Findings in Obesity

January 21, 2025

The properties of ASC30 may allow the small molecule GLP-1 RA to be formulated as a monthly injection and daily oral tablet, Ascletis said.

Tralokinumab Dosing Every 4 Weeks is Effective Maintenance Regimen for Atopic Dermatitis, Study Suggests

January 20, 2025

The key factors predicting stable response to tralokinumab every 4 weeks (vs every 2 weeks) were IGA 0/1 and EASI-75, according to a small post hoc analysis.

RSVPreF Reduces Risk of Severe RSV in Older, High-Risk Adults in Large Real-World Study

January 20, 2025

The new research augments data on efficacy of RSVPreF in older, high-risk adults that was not captured in phase 3 pivotal clinical trials, authors said.

Zyn Nicotine Pouches Get FDA Nod But Not Without Warnings

January 20, 2025

Agency review determined the pouches to be less harmful to health than cigarettes and an aid to smoking cessation but did not declare the products "safe."

Semaglutide 7.2 mg Achieves Weight Reduction of 21% in Late-Stage STEP UP Trial

January 17, 2025

The 20.7% weight loss with the high-dose of semaglutide bested the mean reduction of 17.5% seen with semaglutide 2.4 mg, according to Novo Nordisk.